City of Hope
My research is focused on the development of chimeric antigen receptor (CAR) T cell therapy for the treatment of cancer. I conceptualize, perform and oversee studies to evaluate CAR design, T cell manufacturing, cell-based immunological assays and in vivo animal models. My primary independent research efforts are focused on the development of CAR T cell therapy for the treatment of primary and metastatic brain tumors.
As deputy director of the T Cell Therapeutics Research Laboratory, I also lead multifunctional teams to translate these therapies to the clinical, participating in all stages of the regulatory process.Return to Leadership